4Amrein R, Cano JP, Eckert M, Coassolo P.[Pharmacokinetics of midazolam after i.v. administration (author's transl)]. Arzneimittelforschung,1981,31(12a):2202～2205.
5Campo R, Brullet F, Monserrat A, Calvet X, Rue M, Bordas JM. Factors related to the preference for conscious sedation in upper gastrointestinal endoscopy. Gastroenterology, 1996, 110 (Suppl 4):a8.
6Quine MA, Bell GD, McCloy RF, Charlton JE,Devlin HB, Hopkins A. Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut,1995, 36:462～467.
7Geller E. Report of workshop on drugs for sedation. In: McCloy R, eds. Quality control in endoscopy. Berlin Heidelberg: Spring-Verlag, 1991.22～29.
8Arrowsmith JB, Gerstman BB, Fleischer DE, Benjamin SB. Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc, 1991, 37: 421～427.
9Riker RR,Picard JT,Fraser GL.Prospective evaluation of the Sedation Agitation Scale for adult critically ill patients[].Critical Care Medicine.1999
10Devlin JW,Boleski C,Mlynarek M,et al.Motor Activity Assessment Scale; a valid and reliable sedation for use with mechanically ventilated patient in an adult surgical intensive care unit[].Critical Care Medicine.1999
